Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 14 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Anixa Biosciences Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +7 vs. Q3 2021
- Shares held
- 3.44M
- +260.5K (+8.2%) vs. Q3 2021
- Total value
- $10.2M
- −$4.95M (−32.6%) vs. Q3 2021
- New holders
- 10
- 9 more added
- Sold out
- 3
- 10 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $15.0M |
| Q1 2026 | 60 | $13.1M |
| Q4 2025 | 71 | $17.6M |
| Q3 2025 | 66 | $17.9M |
| Q2 2025 | 66 | $17.6M |
| Q1 2025 | 58 | $16.0M |
| Q4 2024 | 57 | $13.6M |
| Q3 2024 | 58 | $17.6M |
| Q2 2024 | 53 | $12.3M |
| Q1 2024 | 58 | $16.5M |
| Q4 2023 | 55 | $17.2M |
| Q3 2023 | 49 | $12.8M |
| Q2 2023 | 45 | $11.7M |
| Q1 2023 | 44 | $15.8M |
| Q4 2022 | 49 | $15.5M |
| Q3 2022 | 41 | $17.1M |
| Q2 2022 | 45 | $10.0M |
| Q1 2022 | 41 | $9.05M |
| Q4 2021 | 42 | $10.2M |
| Q3 2021 | 35 | $15.2M |
| Q2 2021 | 32 | $11.5M |
| Q1 2021 | 29 | $11.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Anixa Biosciences Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Investors Research Corp | 8 | $0 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 400 | $1.00K | 0.00% | +400 | New |
| Ancora Advisors, LLC | 500 | $1.00K | 0.00% | +500 | New |
| Wells Fargo & Company | 684 | $2.00K | 0.00% | −5,501−88.9% | Reduced |
| JPMorgan Chase & Co | 650 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tradition Wealth Management, LLC | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Accel Wealth Management | 1,250 | $4.00K | 0.00% | +1,250 | New |
| Advisor Group Holdings, Inc. | 1,900 | $6.00K | 0.00% | −2,000−51.3% | Reduced |
| Tower Research Capital LLC (TRC) | 2,923 | $9.00K | 0.00% | −412−12.4% | Reduced |
| Bank of America Corp | 5,065 | $15.0K | 0.00% | −293−5.5% | Reduced |
| First Manhattan Co | 6,500 | $19.0K | 0.00% | 00.0% | Unchanged |
| Adirondack Trust Co | 7,000 | $21.0K | 0.01% | 00.0% | Unchanged |
| Cedar Brook Financial Partners, LLC | 10,000 | $30.0K | 0.01% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 10,029 | $30.0K | 0.00% | +10,029 | New |
| Ameriprise Financial Inc | 12,400 | $37.0K | 0.00% | −2,300−15.6% | Reduced |
| Spire Wealth Management | 14,500 | $43.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 15,712 | $47.0K | 0.00% | +15,712 | New |
| Concorde Asset Management, LLC | 16,000 | $48.0K | 0.03% | +3,000+23.1% | Added |
| Goldman Sachs Group Inc | 16,479 | $49.0K | 0.00% | +16,479 | New |
| B. Riley Wealth Management, Inc. | 17,000 | $50.0K | 0.00% | +5,000+41.7% | Added |
| Segall Bryant & Hamill, LLC | 17,400 | $52.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 19,300 | $57.0K | 0.00% | −26,606−58.0% | Reduced |
| Tyler-Stone Wealth Management | 21,008 | $62.0K | 0.03% | +21,008 | New |
| Long Focus Capital Management, LLC | 21,297 | $63.0K | 0.02% | +21,297 | New |
| Jump Financial, LLC | 26,000 | $77.0K | 0.00% | +26,000 | New |
| Virtu Financial LLC | 28,201 | $84.0K | 0.01% | +16,407+139.1% | Added |
| Citadel Advisors LLC | 33,935 | $101.0K | 0.00% | +19,677+138.0% | Added |
| CoreCap Advisors, LLC | 34,952 | $104.0K | 0.01% | +34,952 | New |
| Two Sigma Investments, LP | 36,350 | $108.0K | 0.00% | −15,700−30.2% | Reduced |
| Marshall Wace, LLP | 41,973 | $125.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 51,838 | $154.0K | 0.00% | −4,700−8.3% | Reduced |
| Morgan Stanley | 54,542 | $162.0K | 0.00% | +11,329+26.2% | Added |
| Raymond James & Associates | 56,902 | $169.0K | 0.00% | +5,352+10.4% | Added |
| Northern Trust Corp | 60,229 | $179.0K | 0.00% | −1,053−1.7% | Reduced |
| State Street Corp | 90,887 | $270.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 98,652 | $293.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 105,168 | $312.0K | 0.00% | −5,124−4.6% | Reduced |
| Geode Capital Management, LLC | 263,951 | $783.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 330,800 | $982.0K | 0.00% | +118,600+55.9% | Added |
| UBS Group AG | 595,799 | $1.77M | 0.00% | +13,391+2.3% | Added |
| Vanguard Group Inc | 1,307,811 | $3.88M | 0.00% | +2,880+0.2% | Added |
| Wealth Alliance Advisory Group, LLC | 0 | $0 | 0.00% | −16,413−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −180−100.0% | Sold out |